Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Inwards

Showing results (71-80 of 179) with videos related to

Pageof 18
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 21, 2020
Outcomes of Autologous Stem Cell Transplant Consolidation in Primary Central Nervous System Lymphoma: A Mayo Clinic ExperienceArushi Khurana, Ivana N Micallef, Betsy R LaPlant, et al.
Leukemia & Lymphoma|September 27, 2019
Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?Mattia Novo, Grzegorz S Nowakowski, Thomas M Habermann, et al.
Cancer|June 11, 2008
Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment GroupStephen M Ansell, David J Inwards, Kendrith M Rowland, et al.
Blood Cancer Journal|January 8, 2021
Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphomaAlessia Castellino, Aung M Tun, Yucai Wang, et al.
Academic Pediatrics|February 13, 2026
Conscientious Objection to Gender-Affirming Care in U.S. Pediatric ResidenciesDanielle J Eble, Alisha L Nguyen, Cole V Roblee, et al.
British Journal of Haematology|February 25, 2012
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphomaLuis F Porrata, Kay Ristow, Thomas M Habermann, et al.
British Journal of Haematology|April 17, 2007
Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomasDeepti Behl, Kay Ristow, Svetomir N Markovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2005
Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphomaThomas E Witzig, Susan M Geyer, Irene Ghobrial, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2009
Phase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hodgkin lymphomaStephen M Ansell, Sara A Hurvitz, Patricia A Koenig, et al.
Mayo Clinic Proceedings|April 10, 2003
Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary reviewMichelle A Elliott, William L Nichols, Elizabeth A Plumhoff, et al.
Pageof 18

Showing results (71-80 of 179) with videos related to

Sort By:
Pageof 18
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 21, 2020
Outcomes of Autologous Stem Cell Transplant Consolidation in Primary Central Nervous System Lymphoma: A Mayo Clinic ExperienceArushi Khurana, Ivana N Micallef, Betsy R LaPlant, et al.
Leukemia & Lymphoma|September 27, 2019
Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?Mattia Novo, Grzegorz S Nowakowski, Thomas M Habermann, et al.
Cancer|June 11, 2008
Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment GroupStephen M Ansell, David J Inwards, Kendrith M Rowland, et al.
Blood Cancer Journal|January 8, 2021
Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphomaAlessia Castellino, Aung M Tun, Yucai Wang, et al.
Academic Pediatrics|February 13, 2026
Conscientious Objection to Gender-Affirming Care in U.S. Pediatric ResidenciesDanielle J Eble, Alisha L Nguyen, Cole V Roblee, et al.
British Journal of Haematology|February 25, 2012
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphomaLuis F Porrata, Kay Ristow, Thomas M Habermann, et al.
British Journal of Haematology|April 17, 2007
Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomasDeepti Behl, Kay Ristow, Svetomir N Markovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2005
Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphomaThomas E Witzig, Susan M Geyer, Irene Ghobrial, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2009
Phase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hodgkin lymphomaStephen M Ansell, Sara A Hurvitz, Patricia A Koenig, et al.
Mayo Clinic Proceedings|April 10, 2003
Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary reviewMichelle A Elliott, William L Nichols, Elizabeth A Plumhoff, et al.
Pageof 18